Therapeutic Antibodies

  • Image of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Disease Building
  • Image of a person using a pipet

    The CPRIT Therapeutic Antibody Core

    We offer Texas-wide access to specialized technical expertise, instrumentation, and automation to advance lead antibodies with “drug like” properties from academic laboratories to the stage of preclinical development.

  • Image of a microscope stage

    Therapeutic Antibody Development

    Lead Identification – Lead Optimization – Lead Construction – Antibody Production

GSBS faculty member Zhiqiang An, PhD

An earns National Academy of Inventors fellowship

January 3, 2022 | Roman Petrowski, McGovern Medical School

GSBS faculty member Zhiqiang An, PhD, has been named a fellow of the National Academy of Inventors (NAI), the organization announced Dec. 7. The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Election to NAI Fellow is the highest professional distinction accorded solely to academic inventors.

Tumors May Shed Protein to Create Barriers that Block Immune Cells

Tumors May Shed Protein to Create Barriers that Block Immune Cells

December 10, 2021 | NCI Staff

Scientists have identified a protein that may help prevent immune cells from entering breast tumors and killing the cancer cells. The research, which was conducted primarily in mice, could lead to potential strategies for overcoming barriers that keep certain immune cells from attacking tumors, according to the investigators.

Research on antibody-drug conjugates shows promise in fighting breast cancer

Research on antibody-drug conjugates shows promise in fighting breast cancer

June 16, 2021 | Roman Petrowski, Office of Communications

Research from the lab of Kyoji Tsuchikama, PhD, assistant professor in the Texas Therapeutics Institute at The Brown Foundation Institute of Molecular Medicine, on a new potential treatment for combating breast cancer has been published in the June edition of Nature Communications.